PHENDIMETRAZINE TARTRATE TABLETS, USP 35 mg
Phendimetrazine tartrate, as the dextro isomer, has the chemical name of (2S,3S)-3,4-dimethyl-2-phenylmorpholine L-(+)-tartrate (1:1).
Phendimetrazine tartrate is indicated in the management of exogenous obesity as a short term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index (BMI) of 30 kg/m2 or higher who have not responded to appropriate weight reducing regimen (diet and/or exercise) alone.
Phendimetrazine tartrate is indicated for use as monotherapy only.
Media Articles Related to Phendimetrazine
Inadequate sleep during teen years increases risk of obesity
Source: Obesity / Weight Loss / Fitness News From Medical News Today [2014.08.22]
Teenagers who don't get enough sleep may wake up to worse consequences than nodding off during chemistry class.
Midlife Obesity May Boost Dementia Risk
Source: Medscape Psychiatry & Mental Health Headlines [2014.08.21]
Risk for subsequent dementia may be highest in individuals with a first record of obesity during their 30s, but the level of risk appears to diminish with increasing age.
Medscape Medical News
Tax on sugar sweetened drinks may reduce obesity in South Africans
Source: Nutrition / Diet News From Medical News Today [2014.08.21]
A suggested tax on sugar sweetened beverages has been given more credence in a research paper by academics from the University of the Witwatersrand in Johannesburg, South Africa.
Pediatricians Must Act Earlier to Prevent Severe Obesity
Source: Medscape Diabetes & Endocrinology Headlines [2014.08.18]
Physicians need more and better tools to combat child and adolescent obesity to try to reduce the numbers joining the ranks of the severely obese, say 2 experts.
Medscape Medical News
Study backs call for publicly funded obesity surgery in Australia
Source: Obesity / Weight Loss / Fitness News From Medical News Today [2014.08.18]
The push for increased access to publicly funded bariatric surgery for obese Australians has beensupported by new research published in the Medical Journal of Australia.
PATIENT REVIEWS / RATINGS / COMMENTS
Based on a total of 1 ratings/reviews, Phendimetrazine has an overall score of 10. The effectiveness score is 10 and the side effect score is 4. The scores are on ten point scale: 10 - best, 1 - worst.
Phendimetrazine review by 27 year old male patient
|Overall rating:|| || |
|Effectiveness:|| || Highly Effective|
|Side effects:|| || Severe Side Effects|
|Condition / reason:|| || weight loss|
|Dosage & duration:|| || 35mg taken 2 times per day for the period of 4 weeks|
|Other conditions:|| || none|
|Other drugs taken:|| || none|
|Benefits:|| || A total of 20 pounds lost in one month. |
|Side effects:|| || Although I reached my goal weight, the drug made me very restless, anxious, moody. I also experienced headaches, and falling asleep was not easy while on this drug. Dizziness, light headed.|
|Comments:|| || Take one 35mg pill in the morning and one after lunch to curb appetite. I fond myself able to stay more active and run longer at the gym. It's a toss up if the results were worth the side effects. It's obvious that a drug this strong that makes you want to run a marathon and not eat can't be good for you!|
Page last updated: 2014-08-22